MA23663A1 - Procede de preparation de formulations pharmaceutiques - Google Patents

Procede de preparation de formulations pharmaceutiques

Info

Publication number
MA23663A1
MA23663A1 MA24005A MA24005A MA23663A1 MA 23663 A1 MA23663 A1 MA 23663A1 MA 24005 A MA24005 A MA 24005A MA 24005 A MA24005 A MA 24005A MA 23663 A1 MA23663 A1 MA 23663A1
Authority
MA
Morocco
Prior art keywords
preparation
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
MA24005A
Other languages
English (en)
Inventor
John Crowley Patrick
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417953A external-priority patent/GB9417953D0/en
Priority claimed from GBGB9503752.9A external-priority patent/GB9503752D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA23663A1 publication Critical patent/MA23663A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA24005A 1994-09-03 1995-09-01 Procede de preparation de formulations pharmaceutiques MA23663A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9417953A GB9417953D0 (en) 1994-09-03 1994-09-03 Pharmaceutical formulations
GBGB9503752.9A GB9503752D0 (en) 1995-02-24 1995-02-24 Pharmaceutical formulations
US46044195A 1995-06-02 1995-06-02

Publications (1)

Publication Number Publication Date
MA23663A1 true MA23663A1 (fr) 1996-04-01

Family

ID=27267365

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24005A MA23663A1 (fr) 1994-09-03 1995-09-01 Procede de preparation de formulations pharmaceutiques

Country Status (8)

Country Link
EP (1) EP0782443A1 (fr)
JP (1) JPH10505595A (fr)
AU (1) AU3471995A (fr)
DZ (1) DZ1926A1 (fr)
IL (1) IL115125A0 (fr)
MA (1) MA23663A1 (fr)
TR (1) TR199501082A2 (fr)
WO (1) WO1996007408A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL325411A1 (en) 1995-09-07 1998-07-20 Smithkline Beecham Corp Pharmaceutic preparation
EA002595B1 (ru) * 1997-02-14 2002-06-27 Смитклайн Бичем Лаборатуар Фармасетик Фармацевтический препарат, содержащий амоксициллин и клавуланат, способ его приготовления и гранулят, содержащий амоксициллин и клавуланат
DE69922202T2 (de) * 1998-07-06 2005-12-01 Nanobac Oy Verfahren zur beseitigung von nanobakterien
US6706290B1 (en) 1998-07-06 2004-03-16 Olvai E. Kajander Methods for eradication of nanobacteria
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (fr) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Nouvelle formulation
US8614315B2 (en) * 2009-12-25 2013-12-24 Mahmut Bilgic Cefdinir and cefixime formulations and uses thereof
TR201000688A2 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
WO2011152806A1 (fr) * 2010-06-03 2011-12-08 Mahmut Bilgic Méthode de production de formulation effervescente comprenant du céphalosporine et du clavulanate de potassium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002312B1 (fr) * 1977-11-26 1982-02-03 Beecham Group Plc Dérivés de l'acide clavulanique et compositions pharmaceutiques les contenant
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP1034784A3 (fr) * 1993-01-22 2001-06-27 Smithkline Beecham Plc Formulations pharmaceutique contenant d'acide clavulanique et un agent antibacterien

Also Published As

Publication number Publication date
WO1996007408A1 (fr) 1996-03-14
AU3471995A (en) 1996-03-27
JPH10505595A (ja) 1998-06-02
IL115125A0 (en) 1995-12-31
TR199501082A2 (tr) 1996-06-21
EP0782443A1 (fr) 1997-07-09
DZ1926A1 (fr) 2002-02-17

Similar Documents

Publication Publication Date Title
MA23528A1 (fr) Procede de preparation de produits pharmaceutiques
FR2722984B1 (fr) Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
MA23850A1 (fr) Procede de preparation de compositions vaccinantes
MA23918A1 (fr) Procede de preparation de compositions vaccinantes
MA23814A1 (fr) Procede de preparation de compositions vaccinantes
MA23395A1 (fr) Procede de preparation de nouvelles formulations
ITMI950529A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
FI973281L (fi) Menetelmä tiettyjen atsasykloheksapeptidien valmistamiseksi
MA24291A1 (fr) Procede pour la preparation de compositions de vaccin
MA24437A1 (fr) Procede de la preparation et de la formulation de dihydrate d'eprosartan
FR2722210B1 (fr) Nouvelles streptogramines et procede de preparation de streptogramines par mutasynthese
MA24246A1 (fr) Procede de preparation de frites dorees au four ameliorees
MA23518A1 (fr) Procede de preparation de produits pharmaceutiques
MA23663A1 (fr) Procede de preparation de formulations pharmaceutiques
EP0763097A4 (fr) Procede d'elaboration des acides tetrahydroisoalpha
FR2728895B1 (fr) Procede de preparation du difluoromethane
MA24183A1 (fr) Procede pour la preparation de compositions pharmaceutiques a base de diclofenac
FR2728268B1 (fr) Procede de preparation de gamma-cyclodextrine
FR2768725B1 (fr) Procede de preparation du 2-chloroprop-1-ene
EP0823904A4 (fr) Procede de preparation de spiroindolines
MA22880A1 (fr) Procede de preparation de produits pharmaceutiques .
ITMI951417A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
EP0932601A4 (fr) Procede de preparation de composes pharmaceutiques
NO980384D0 (no) Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler